Axcella Health, Inc.
(NASDAQ : AXLA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.01%152.520.0%$4782.73m
NVAXNovavax, Inc. -2.25%126.2592.9%$675.98m
BNTXBioNTech SE 1.11%120.000.0%$672.24m
AMGNAmgen, Inc. 1.01%229.211.3%$578.56m
GILDGilead Sciences, Inc. 1.15%61.561.0%$506.97m
BIIBBiogen, Inc. 0.73%245.871.7%$496.02m
REGNRegeneron Pharmaceuticals, Inc. -1.28%492.452.7%$472.10m
VRTXVertex Pharmaceuticals, Inc. 0.64%228.321.9%$455.95m
ILMNIllumina, Inc. 1.35%350.663.5%$426.07m
EXASEXACT Sciences Corp. 1.68%132.8719.6%$207.83m
SGENSeagen Inc. -0.52%179.235.8%$156.07m
BGNEBeiGene Ltd. 0.71%222.881.4%$141.27m
CRSPCRISPR Therapeutics AG 5.04%147.540.6%$137.84m
TXG10X Genomics, Inc. 2.63%149.040.0%$136.40m
SRNESorrento Therapeutics, Inc. 0.00%7.971.4%$136.15m

Company Profile

Axcella Health, Inc. is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. Its product pipeline includes AXA1665, AXA1125, AXA1957, AXA2678, and AXA4010. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.